Dr. Paul R. Helft, MD
- Medicare services, 2024
- 864
- Medicare patients, 2024
- 173
- Part D claims, 2024
- 905
- Publications
- 75
- Clinical trials
- 2
- Practice address
- 2900 W 16th St, Bedford, IN 47421
- Practice phone
- Call (812) 275-1200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Helft's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Paul R. Helft is a hematologist and oncologist in Bedford, Indiana
Dr. Helft practices at IU Health Bedford Hospital in Bedford, Indiana, part of Indiana University Health.
Dr. Helft's NPI, 1417912387, was assigned on April 20, 2006. Dr. Helft holds Indiana license 01053811.
- NPI
- 1417912387NPI Registry (opens in a new tab)
- NPI enumeration date
- April 20, 2006
- NPI status
- Active
- Practice phone
- (812) 275-1200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Paul R. Helft practices at IU Health Bedford Hospital in Bedford, Indiana
Dr. Helft's primary practice is IU Health Bedford Hospital, at 2900 W 16th St, Bedford, IN 47421 in Lawrence County. The practice phone is (812) 275-1200.
- IU Health Bedford Hospital2900 W 16th St, Bedford, IN 47421 · Lawrence CountyPhone(812) 275-1200
Source: Dmand AI Affiliation Data
Dr. Paul R. Helft is affiliated with 1 site of care and 2 medical groups
Dr. Helft's primary practice is IU Health Bedford Hospital in Bedford, Indiana, part of Indiana University Health. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Helft to 1 more medical group, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Paul R. Helft's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Helft practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| IU Health Bedford Hospital | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Indiana University Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Paul R. Helft is one of 224 hematologists and oncologists in Indiana
Hematology and oncology is Dr. Helft's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Helft is licensed in Indiana.
Specialties and state licenses
- Hematology and oncology, IndianaPrimary
Hematologists and oncologists near Dr. Helft
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Paul R. Helft billed Medicare for 864 services in 2024
CMS data shows 864 Medicare services from Dr. Helft across 6 procedure codes in 2024, for 173 Medicare patients. Medicare paid $44,257 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Helft's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5692024: 5189%
- Other services
- 2023: 02024: 346
Dr. Helft compared with the Indiana median for hematologists and oncologists, 2024
- Dr. Helft
- Indiana median
- Medicare services
- 864vs 76014% above
- Medicare patients
- 173vs 26434% below
- Part D claims
- 659vs 42356% above
Medians across 215 hematologists and oncologists in Indiana with Dmand AI profiles that report each measure.
Dr. Helft's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Helft?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Helft and other hematologists and oncologists in Indiana.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Paul R. Helft treated 173 Medicare patients in 2024, average age 72
CMS counts 173 Medicare patients who saw Dr. Helft in 2024. The largest group is 65 to 74, with 94 patients. 72% of them have high blood pressure, and 63% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Helft's median patient age at 64, with 51% women.
Dr. Helft's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Helft's Medicare patients by sex, 2024
- Women8147%
- Men9253%
Chronic conditions among Dr. Helft's Medicare patients, 2024
- High blood pressure72%
- High cholesterol63%
- Cancer42%
- Arthritis35%
- Diabetes34%
- Chronic kidney disease26%
- Depression26%
- Mood disorders26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Helft's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 64
Patient panel by sex, all payers
- Women51%
- Men49%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Paul R. Helft wrote 905 Medicare Part D claims in 2024
In 2024, Dr. Helft wrote 905 Medicare Part D claims for 91 patients. 84% of them were for generic drugs. CMS names the drug for 659 of them, across 25 drugs with 11 or more claims each, at $153,218 in total drug cost. In 2023, CMS named 571 claims across 21 drugs.
Dr. Helft's Part D claims by kind of drug, 2024
- Generic764 claims84%
- Brand-name and other141 claims16%
Dr. Helft's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Helft's Part D claims, 2024
- Opioids21%193 of 905 claims
- Antibiotics3%23 of 905 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5712024: 65915%
Drugs named by CMS: 25 in 2024, 21 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Paul R. Helft has 75 publications on record
Dmand AI links 75 papers to Dr. Helft, published from 2003 to 2025. 2017 was the busiest year, with 5. The most frequent topics are Communication, Physician-Patient Relations and Decision Making. Dr. Helft has published most often in J Clin Oncol. Dr. Helft's most frequent co-authors are Safi Shahda, MD, Patrick J. Loehrer, MD and Amikar Sehdev, MD.
Dr. Helft's papers by year, 2016 to 2025
Topics Dr. Helft writes about most
- Communication
- Physician-Patient Relations
- Decision Making
- Caregivers
- Terminal Care
- Adaptation, Psychological
- Colorectal Neoplasms
- Medical Oncology
Dr. Helft's most frequent co-authors
Recent publications by Dr. Helft
See who Dr. Helft researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Helft works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Paul R. Helft has worked on 2 clinical trials
Dmand AI links Dr. Helft to 2 clinical trials. Conditions studied include Neoplasm Metastasis and Neoplastic Processes.
Clinical trials with Dr. Helft by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Helft's trials
- Neoplasm Metastasis
- Neoplastic Processes
Investigators on the most trials with Dr. Helft
- Minsig Choi, MD1 shared trial
- Michael Francis Driscoll, MD1 shared trial
- Diana L. Hanna, MD1 shared trial
Recent clinical trials with Dr. Helft
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Paul R. Helft received $17,372 in industry payments from 2016 to 2025
CMS Open Payments shows 21 general payments to Dr. Helft from 4 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Genentech, Inc. paid the most, $9,032.
General payments to Dr. Helft by program year, 2016 to 2025
General payments to Dr. Helft by kind, 2016 to 2025
- Consulting fees$7,38543%
- Speaker and faculty fees$6,68838%
- Travel and lodging$2,67515%
- Food and beverage$6063%
- Education$180%
Companies that paid Dr. Helft the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Paul R. Helft's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Paul R. Helft
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Paul R. Helft's NPI number?
Dr. Paul R. Helft's NPI number is 1417912387. It was assigned on April 20, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Paul R. Helft?
Dr. Paul R. Helft is a hematologist and oncologist in Bedford, Indiana. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Paul R. Helft practice?
Dr. Helft practices at 2900 W 16th St, Bedford, IN 47421. Dr. Helft's primary practice is IU Health Bedford Hospital in Bedford, Indiana, part of Indiana University Health. Dmand AI also links Dr. Helft to 1 medical group.
What is Dr. Paul R. Helft's office phone number?
The practice phone on file for Dr. Helft is (812) 275-1200.
What is Dr. Paul R. Helft's medical license number?
Dr. Helft holds Indiana license 01053811.
Which hospitals is Dr. Paul R. Helft affiliated with?
Dr. Helft practices at IU Health Bedford Hospital in Bedford, Indiana.
What medical group is Dr. Paul R. Helft part of?
Dr. Helft is linked to IU Health Medical Group. Dmand AI links Dr. Helft to 1 more medical group.
Does Dr. Paul R. Helft accept Medicare?
Yes. CMS data shows Dr. Helft billed Medicare for 864 services in 2024.
How many Medicare patients does Dr. Paul R. Helft see?
CMS counts 173 Medicare patients who saw Dr. Helft in 2024, with an average age of 72.
What services does Dr. Paul R. Helft bill to Medicare?
In 2024, Dr. Helft's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
Show 5 more questionsShow fewer questions
What drugs does Dr. Paul R. Helft prescribe most?
In 2024 Medicare Part D data, Dr. Helft's most prescribed drugs by claims were Oxycodone HCl, Dexamethasone and Ondansetron HCl.
Has Dr. Paul R. Helft received payments from drug or device companies?
CMS Open Payments shows $17,372 in general payments to Dr. Helft from 4 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. Paul R. Helft been practicing?
Dr. Helft graduated from medical school in 1995, 31 years ago.
Does Dr. Paul R. Helft do research?
Dmand AI links 75 publications to Dr. Helft, published from 2003 to 2025. Dr. Helft has worked on 2 clinical trials.
Who does Dr. Paul R. Helft publish with?
Dr. Helft's most frequent co-authors are Safi Shahda, MD (8 shared papers), Patrick J. Loehrer, MD (5 shared papers) and Amikar Sehdev, MD (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Indiana by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card